---
title: "TIANYU PHARM: The active pharmaceutical ingredient of Irbesartan (Process II) has obtained the CEP certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/244456541.md"
description: "TIANYU PHARM announced that the company has obtained the Certificate of Suitability to the European Pharmacopoeia (CEP certificate) for the active pharmaceutical ingredient Eprosartan (Process II) issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM). This drug is used for the treatment of primary hypertension and hypertension-related type 2 diabetic nephropathy. The company submitted the drug registration application to EDQM in December 2024 and successfully obtained the CEP certificate"
datetime: "2025-06-13T12:46:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/244456541.md)
  - [en](https://longbridge.com/en/news/244456541.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/244456541.md)
---

# TIANYU PHARM: The active pharmaceutical ingredient of Irbesartan (Process II) has obtained the CEP certificate

According to the Zhitong Finance APP, TIANYU PHARM (300702.SZ) announced that the company has received the Certificate of Suitability for European Pharmacopoeia (CEP) issued by the European Directorate for the Quality of Medicines and HealthCare (EDQM) for the active pharmaceutical ingredient of Irbesartan (Process II).

Irbesartan is an antihypertensive medication used for the treatment of primary hypertension and for the treatment of hypertension in patients with type 2 diabetes and nephropathy. The company submitted the drug registration application for Irbesartan (Process II) to EDQM in December 2024 and obtained the CEP certificate

### Related Stocks

- [300702.CN](https://longbridge.com/en/quote/300702.CN.md)

## Related News & Research

- [Trump may eye cuts to capital gains tax for home sellers, official says](https://longbridge.com/en/news/295703528.md)
- [FDA Issues Warning About Certain Products Containing Toxic Yellow Oleander](https://longbridge.com/en/news/295690341.md)
- [Friedrich Vorwerk buys meterQ gas measurement and analysis business](https://longbridge.com/en/news/295685017.md)
- [SHUKRAPHAR: Strong revenue and profit growth in Q1 FY27, with robust performance in the pharmaceutical segment](https://longbridge.com/en/news/295639972.md)
- [‘A Change Has Come,’ Says Top Investor About SpaceX Stock](https://longbridge.com/en/news/295554054.md)